A section of ex-Ranbaxy medical representatives (MRs) had challenged in the industrial court in Mumbai the move by Sun Pharma to do away with a software application used by erstwhile Ranbaxy MRs for reporting daily activity reports (DAR) and asked them to switch over to a system provided by it.
The industrial court had granted an interim order in favour of the medical representatives. It was challenged by the company in the Bombay High Court.
The court "has granted the company's request for using the Target Application as the platform for DAR and passed an order in which it has directed the said MRs to start reporting on the Target Application retrospectively", Sun Pharma said in a filing to the BSE.
As on today the migration of all medical representatives of the erstwhile Ranbaxy to Target Application has been completed and around 94 per cent of them are reporting on it. The balance 6 per cent are refusing to submit their DAR on Target Application, Sun Pharma said.
As part of the integration of erstwhile Ranbaxy in Sun Pharma, it was decided to use Target Application as a single platform for DAR for the India field force, it added.